Foundations of Peripheral Blood Biomarker Signatures and Immune Stratification John Murphy, M.D., M.P.H., D.P.H, President, COVID-19 Long-haul Foundation Summary Post–acute sequelae of SARS-CoV-2 infection (PASC), commonly termed Long COVID, is […]
Post-Acute SARS-CoV-2 Infection
Historical Context, Paradigm Shift, and Emergence of Immunothrombosis as a Central Framework John Murphy, M.D, M.P.H., D.P.H. President Covid-19 Long-haul Foundation Abstract Post–acute sequelae of SARS-CoV-2 infection (PASC), commonly termed […]
Influenza A (H1N1) and COVID-19 Pneumonias: An Evaluation in the Light of New Hematologic Indices
Yeşildağ M , Kocabas R, DOI https://doi.org/10.2147/JIR.S54538 Objective: Influenza A (H1N1) and COVID-19 viruses are two very different airway viral pneumonia agents that cause similar clinical manifestations and coinfections. The aim of this […]
Prognostic Value of Peripheral Blood in Different Infection Status in COVID-19 Patients
Zhu M , Cheng J , He L, et. al., DOI https://doi.org/10.2147/JIR.S519226Objective: To explore the value of the neutrophil CD64 (nCD64) index, monocytic HLA-DR (mHLA-DR), and the percentage of CD14+ monocytes in the prognosis of Coronavirus disease […]
Microclot Formation and Fibrinolytic Resistance in Long COVID: Mechanisms, Biomarkers, and Visualization
Author: John Murphy, President, COVID-19 Long-haul Foundation Abstract Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), has emerged as a chronic multisystem condition affecting millions globally. Among its most […]
Diagnostic Biomarkers and Imaging Modalities in Long COVID: Toward Precision Detection and Monitoring
Author: John Murphy, President, COVID-19 Long-haul Foundation Abstract Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), presents with a complex array of symptoms affecting multiple organ systems. Accurate diagnosis […]
Long COVID continues to stick around. Scientists may finally know why
The Conversation, Research led by Brendan Crabb, Gabriela Khoury, and Michelle Scoullar, Burnet Institute Around 5–10% of people with COVID infections go on to experience long COVID, with symptoms lasting three months […]
Endothelial Disruption in Long COVID: Unraveling the Vascular Legacy of SARS-CoV-2
John Murphy, The COVID 19 Long-haul Foundation Abstract Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), has emerged as a chronic multisystem disorder affecting millions worldwide. Among its most […]
🩸 COVID-19 and Blood Morphology: Insights from 2025 Peer-Reviewed Research
As the global understanding of COVID-19 deepens, 2025 research has illuminated how SARS-CoV-2 affects blood morphology, particularly red blood cells (RBCs), hemoglobin function, and hematopoiesis. These changes are not only […]
COVID-19 coagulopathy, thrombosis, and bleeding
Noel C. Chan, Jeffrey I. Weitz, Blood (2020) 136 (4): 381–383. In this issue of Blood, Al-Samkari et al expand our understanding of thrombosis and bleeding risks and their predictors in hospitalized patients with […]